James A. Bianco, MD

James A. Bianco, MD has a diverse and extensive work experience in the biotechnology and medical fields. James A. currently serves as the Chief Executive Officer of Morphogenesis, Inc., a clinical-stage biotechnology company focused on developing personalized immunotherapies for advanced rare cancers. Their role involves advancing the field of immunotherapy, overcoming mechanisms by which tumors can escape immune recognition, and improving immune cell attack on tumor cells.

Prior to their current position, Dr. Bianco was the Executive Chairman and Principal Founder of TUHURA Biopharma Inc. from 2019 onwards. James A. also held the position of Managing Director at Hidden Value Consulting LLC since 2016.

Dr. Bianco's experience includes serving as the Chief Development Officer at Drais Pharmaceuticals from 2018 to 2021, where they were responsible for the development of therapeutic drugs. James A. also held the role of President & CEO, as well as Board Member and Principal Founder, at CTI BioPharma from 1992 to 2016. At CTI BioPharma, they were involved in all aspects of drug development, including clinical phases, regulatory negotiations, and market access.

Additionally, Dr. Bianco has contributed to the field through their research and academic roles. James A. worked as an Assistant Member at the Fred Hutchinson Cancer Research Center from 1990 to 1992, focusing on pharmacologic regulation of inflammatory cytokines. James A. also served as an Assistant Professor of Medicine and Director of the Marrow Transplant Unit at the University of Washington, where they conducted research on targeted radioimmunotherapy and investigated the role of inflammatory mediators in regimen-related toxicity.

Furthermore, Dr. Bianco's early career included a fellowship in the Hematology Oncology Program at the University of Washington, where they received the 1990 ISEH Young Investigator Award. James A. also worked at Mount Sinai Medical Center as the Chief Medical Resident.

Dr. Bianco's work experience showcases their expertise in biotechnology, drug development, immunotherapy, and cancer research, as well as their leadership roles in various organizations.

James A. Bianco, MD has an extensive education history. James A. attended Bronx High School of Science from 1970 to 1974. James A. then pursued their undergraduate studies at New York University from 1976 to 1979, earning a Bachelor of Science (B.S.) degree in Biology and Physics.

After completing their undergraduate studies, Dr. Bianco enrolled at Icahn School of Medicine at Mount Sinai in 1979. James A. completed their Doctor of Medicine (MD) degree and an Internal Medicine Residency Program at Mount Sinai from 1979 to 1983. Additionally, they completed a Medical Oncology Residency Program at the same institution from 1983 to 1983 for further specialization in the field of medical oncology.

Dr. Bianco later attended the University of Washington - School of Medicine from 1988 to 1990, where they obtained their Doctor of Medicine (M.D.) degree in Hematology-Oncology. Finally, they further specialized in stem cell transplantation by completing a program at Fred Hutchinson Cancer Research Center from 1987 to 1992.

Overall, Dr. James A. Bianco, MD has a diverse educational background, encompassing both medical and scientific studies, which have provided him with the necessary knowledge and expertise in the fields of stem cell transplantation, medical oncology, and internal medicine.